减重手术与病态肥胖患者癌症风险的关联
本研究比较了接受袖状胃切除术(VSG)、Roux-en-Y胃旁路术(RYGB)或无手术干预的病态肥胖患者的肥胖相关癌症发生率。通过1:1:1匹配创建三组,结果显示未手术组多种癌症发生率显著更高,RYGB组结直肠癌风险显著降低(OR 0.47,95%CI 0.30-0.75),VSG组肺癌风险显著降低(OR 0.42,95%CI 0.25-0.70)。
要点
- 未手术的病态肥胖患者任何癌症发生率4.61%,高于手术组。
- RYGB与结直肠癌风险降低相关(OR 0.47,95%CI 0.30-0.75)。
- VSG与肺癌风险降低相关(OR 0.42,95%CI 0.25-0.70)。
核心结论
- 接受VSG或RYGB的病态肥胖患者术后任何癌症、肺癌、卵巢癌和子宫癌发生率显著低于符合减重手术条件但未手术的患者。
主要发现
- 未手术组任何癌症发生率为4.61%,子宫癌0.86%,结直肠癌0.57%,肺癌0.50%,均高于手术组。
- RYGB组结直肠癌风险显著低于未手术组(OR 0.47,95%CI 0.30-0.75)。
- VSG组肺癌风险显著低于未手术组(OR 0.42,95%CI 0.25-0.70)。
关键数值与推荐
- RYGB与结直肠癌风险降低相关:OR 0.47,95%CI 0.30-0.75。
- VSG与肺癌风险降低相关:OR 0.42,95%CI 0.25-0.70。
- 未手术组任何癌症发生率4.61%,子宫癌0.86%,结直肠癌0.57%,肺癌0.50%。
临床怎么用
- 对于符合减重手术条件的病态肥胖患者,VSG或RYGB可能降低特定癌症风险,临床决策时可考虑癌症风险获益。
局限性
- 本研究为回顾性设计,可能存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study investigates the rates of obesity-related cancers in patients undergoing vertical sleeve gastrectomy (VSG), Roux-en-Y gastric bypass (RYGB), or no surgical intervention. SUMMARY BACKGROUND DATA: Obesity has been previously associated with increased rates of cancers; however, weight loss surgeries have not been explored to demonstrate their potential risk reduction impact. METHODS: Patients meeting bariatric eligibility criteria between January 2010 and December 2018 were identified. Exact 1:1:1 matching based on baseline patient demographics and comorbidities was used to create 3 groups with identical covariates: patients undergoing VSG, RYGB, and no surgery. RESULTS: A total of 28, bariatric-eligible patients equally split into patients undergoing VSG (n = 9636, 33.3%), RYGB (n = 9636, 33.3%), and those with no surgical intervention (n = 9636, 33.3%). Bariatric-eligible patients that did not undergo surgical intervention had significantly higher rates and odds of developing numerous cancer types included in our study when compared to either surgical cohorts, with any cancer type (4.61%), uterine (0.86%), colorectal (0.57%), and lung cancers (0.50%) being most common. Individuals undergoing RYGB were significantly less likely to develop colorectal cancer compared to patients without any surgical intervention [odds ratio (OR) 0.47, 95% confidence interval (CI) 0.30-0.75]. Additionally, those undergoing VSG were significantly less likely to develop lung cancer than the bariatric eligible no surgery cohort (OR 0.42, 95% CI 0.25-0.70). CONCLUSION: Postoperative rates of any cancer type, lung, ovarian, and uterine cancer were significantly lower in obese patients undergoing either vertical sleeve gastrectomy (VSG) or RYGB compared to bariatric-eligible patients without any surgical intervention.
引用
- Khalid SI, Maasarani S, Wiegmann J, et al. Association of Bariatric Surgery and Risk of Cancer in Patients With Morbid Obesity. Ann Surg. 2022. PMID: 34183506. doi:10.1097/SLA.0000000000005035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。